Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Stockholders Equity Over TimeStable
Percentile Rank71
3Y CAGR-23.6%
5Y CAGR+42.1%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-23.6%/yr
vs +52.3%/yr prior
5Y CAGR
+42.1%/yr
Recent deceleration
Acceleration
-75.9pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
5.8x
Strong expansion
Streak
3 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $32.76M | -10.0% |
| 2023 | $36.38M | -45.3% |
| 2022 | $66.48M | -9.6% |
| 2021 | $73.55M | +19.9% |
| 2020 | $61.32M | +986.4% |
| 2019 | $5.64M | -36.0% |
| 2018 | $8.81M | -35.5% |
| 2017 | $13.67M | -24.1% |
| 2016 | $18.01M | -18.0% |
| 2015 | $21.97M | - |